CASTLE BIOSCIENCES, INC. Income (Loss) Attributable to Parent, before Tax
CASTLE BIOSCIENCES, INC. (CSTL) reported Income (Loss) Attributable to Parent, before Tax of -$1.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for the quarter ending 2026-06-30 was -$1.69M.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for the quarter ending 2026-03-31 was -$14.41M.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for the quarter ending 2025-12-31 was -$2.71M, a 134.42% decline year-over-year.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for the quarter ending 2025-09-30 was -$386.00K, a 104.66% decline year-over-year.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for fiscal 2025 was -$29.51M, a 236.87% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for fiscal 2024 was $21.56M.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for fiscal 2023 was -$57.37M.
- CASTLE BIOSCIENCES, INC. income (loss) attributable to parent, before tax for fiscal 2022 was -$68.90M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 3 month as first filed | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 6 month as first filed | Income (Loss) Attributable to Parent, before Tax 9 month | Income (Loss) Attributable to Parent, before Tax 9 month as first filed | Income (Loss) Attributable to Parent, before Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.69M 10-Q · filed 2026-07-30 | -$16.10M 10-Q · filed 2026-07-30 | -$18.82M derived: sum of 3 quarters · filed 2026-07-30 | -$19.20M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | -$14.41M 10-Q · filed 2026-05-06 | -$17.13M derived: sum of 2 quarters · filed 2026-05-06 | -$17.51M derived: sum of 3 quarters · filed 2026-05-06 | -$17.66M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.10M derived: sum of 2 quarters · filed 2026-02-26 | -$3.24M derived: sum of 3 quarters · filed 2026-07-30 | -$29.51M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$386.00K 10-Q · filed 2025-11-03 | -$529.00K derived: sum of 2 quarters · filed 2026-07-30 | -$26.80M 10-Q · filed 2025-11-03 | -$18.91M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$143.00K 10-Q · filed 2026-07-30 | -$26.41M 10-Q · filed 2026-07-30 | -$18.53M derived: sum of 3 quarters · filed 2026-07-30 | -$10.25M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$26.27M 10-Q · filed 2026-05-06 | -$18.39M derived: sum of 2 quarters · filed 2026-05-06 | -$10.10M derived: sum of 3 quarters · filed 2026-05-06 | -$2.22M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.17M derived: sum of 2 quarters · filed 2026-02-26 | $24.05M derived: sum of 3 quarters · filed 2026-02-26 | $21.56M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $8.28M 10-Q · filed 2025-11-03 | $16.17M derived: sum of 2 quarters · filed 2025-11-03 | $13.68M 10-Q · filed 2025-11-03 | $11.14M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $7.89M 10-Q · filed 2025-08-04 | $5.40M 10-Q · filed 2025-08-04 | $2.86M derived: sum of 3 quarters · filed 2026-02-26 | -$4.02M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$2.49M 10-Q · filed 2025-05-05 | -$5.03M derived: sum of 2 quarters · filed 2026-02-26 | -$11.90M derived: sum of 3 quarters · filed 2026-02-26 | -$30.66M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.41M derived: sum of 2 quarters · filed 2026-02-26 | -$28.18M derived: sum of 3 quarters · filed 2026-02-26 | -$57.37M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$6.87M 10-Q · filed 2024-11-04 | -$25.63M derived: sum of 2 quarters · filed 2024-11-04 | -$54.82M 10-Q · filed 2024-11-04 | -$75.39M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$18.76M 10-Q · filed 2024-08-05 | -$47.95M 10-Q · filed 2024-08-05 | -$68.51M derived: sum of 3 quarters · filed 2025-02-27 | -$88.76M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | -$29.19M 10-Q · filed 2024-05-02 | -$49.75M derived: sum of 2 quarters · filed 2025-02-27 | -$70.00M derived: sum of 3 quarters · filed 2025-02-27 | -$73.61M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$20.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$40.81M derived: sum of 2 quarters · filed 2025-02-27 | -$44.41M derived: sum of 3 quarters · filed 2025-02-27 | -$68.90M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$20.25M 10-Q · filed 2023-11-02 | -$23.85M derived: sum of 2 quarters · filed 2023-11-02 | -$48.34M 10-Q · filed 2023-11-02 | -$63.50M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | -$3.60M 10-Q · filed 2023-08-02 | -$28.09M 10-Q · filed 2023-08-02 | -$43.25M derived: sum of 3 quarters · filed 2023-08-02 | -$55.04M derived: sum of 4 quarters · filed 2023-08-02 | |||
| 2022-03-31 | -$24.49M 10-Q · filed 2023-05-03 | -$39.64M derived: sum of 2 quarters · filed 2023-05-03 | -$51.44M derived: sum of 3 quarters · filed 2023-05-03 | -$60.22M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | -$15.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$26.95M derived: sum of 2 quarters · filed 2023-02-28 | -$35.73M derived: sum of 3 quarters · filed 2023-02-28 | -$40.01M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | -$11.79M 10-Q · filed 2022-11-02 | -$20.58M derived: sum of 2 quarters · filed 2022-11-02 | -$24.86M 10-Q · filed 2022-11-02 | -$29.66M derived: sum of 4 quarters · filed 2022-11-02 | |||
| 2021-06-30 | -$8.79M 10-Q · filed 2022-08-08 | -$13.07M 10-Q · filed 2022-08-08 | -$17.87M derived: sum of 3 quarters · filed 2022-08-08 | -$22.46M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | -$4.28M 10-Q · filed 2022-05-09 | -$9.09M derived: sum of 2 quarters · filed 2022-05-09 | -$13.67M derived: sum of 3 quarters · filed 2022-05-09 | -$15.05M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$9.39M derived: sum of 2 quarters · filed 2022-02-28 | -$10.77M derived: sum of 3 quarters · filed 2022-02-28 | -$10.20M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | -$4.59M 10-Q · filed 2021-11-08 | -$5.96M derived: sum of 2 quarters · filed 2021-11-08 | -$5.39M 10-Q · filed 2021-11-08 | -$3.27M derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | -$1.38M 10-Q · filed 2021-08-09 | -$806.00K 10-Q · filed 2021-08-09 | $1.32M derived: sum of 3 quarters · filed 2021-08-09 | $7.17M derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $570.00K 10-Q · filed 2021-05-10 | $2.70M derived: sum of 2 quarters · filed 2021-05-10 | $8.55M derived: sum of 3 quarters · filed 2021-05-10 | $7.28M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $7.98M derived: sum of 2 quarters · filed 2021-03-11 | $6.71M derived: sum of 3 quarters · filed 2021-03-11 | $5.35M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $5.85M 10-Q · filed 2020-11-09 | $5.85M 10-Q · filed 2019-11-12 | $4.58M derived: sum of 2 quarters · filed 2020-11-09 | $3.22M 10-Q · filed 2020-11-09 | $3.22M 10-Q · filed 2019-11-12 | $7.10M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | -$1.27M 10-Q · filed 2020-08-10 | -$1.27M 10-Q · filed 2019-09-03 | -$2.63M 10-Q · filed 2020-08-10 | -$2.63M 10-Q · filed 2019-09-03 | $1.25M derived: sum of 3 quarters · filed 2020-08-10 | -$2.20M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$1.36M 10-Q · filed 2020-05-11 | $2.52M derived: sum of 2 quarters · filed 2020-05-11 | -$930.59K derived: sum of 3 quarters · filed 2020-05-11 | -$4.09M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $427.41K derived: sum of 2 quarters · filed 2020-03-10 | -$2.73M derived: sum of 3 quarters · filed 2020-03-10 | -$6.36M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | -$3.45M 10-Q · filed 2019-11-12 | -$6.61M derived: sum of 2 quarters · filed 2019-11-12 | -$10.24M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$3.15M 10-Q · filed 2019-09-03 | -$6.79M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |